Daily non-political popular news in brief.

Breakthrough MS treatment doesn't reach US patients

Many US multiple sclerosis (MS) patients aren't receiving the latest drug therapies, according to research published in the online journal BMC Medicine. Immunomodulatory agents (IMAs) could slow the progress of the disease, but are only prescribed in a minority of cases, and mostly by neurologists.

Read more »

Keywords: breakthrough, treatment, doesn, reach, patients, patient

« Previous | Next »

Similar news on "Breakthrough MS treatment doesn't reach US patients":

1. MRI of the ankle changes patient treatment and improves referring physician confidence in diagnosis
   01-05-2007 · EurekAlert!
   MR imaging can make a dramatic difference in the management of patients with ankle pain, changing treatment in about one-third of the patients, a new study finds.
   Similar news · Read more »
   
2. Cost control measures limit patient and physician choice in psychotropic medications
   03-01-2007 · EurekAlert!
   A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University.
   Similar news · Read more »
   
3. Quantitative PET imaging finds early determination of effectiveness of cancer treatment
   10-23-2007 · EurekAlert!
   With positron emission tomography imaging, seeing is believing: evaluating a patient's response to chemotherapy for non-Hodgkin lymphoma typically involves visual interpretation of scans of cancer tumors. Researchers have found that measuring a quantitative index -- one that reflects the reduction of metabolic activity after chemotherapy first begins -- adds accurate information about patients' responses to first-line chemotherapy, according to a study in the October issue of the Journal of Nuclear Medicine.
   Similar news · Read more »
   
4. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
   01-31-2008 · EurekAlert!
   Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
   Similar news · Read more »
   
5. Further breakthroughs for breast cancer patients
   01-18-2008 · EurekAlert!
   Researchers at the Tenovus Centre for Cancer Research at Cardiff University have made a breakthrough in breast cancer treatment that could help save the lives of women who become resistant to breast cancer drugs such as tamoxifen.
   Similar news · Read more »
   
6. Pre-treatment blood test could guide lung cancer therapy
   06-05-2007 · EurekAlert!
   A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
   Similar news · Read more »
   
7. How do patients choose the best treatment for their disease?
   10-03-2007 · EurekAlert!
   The diagnosis has come in, and it's not good. Worse, the patient has to choose from treatment options that are sometimes contradictory and risky. None of them promises complete success. How do patients make an informed decision, choosing the very best treatment for their own healthcare?
   Similar news · Read more »
   
8. Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
   12-20-2007 · EurekAlert!
   The largest study to examine the effect of depression on HIV treatment appears in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The study by Kaiser Permanente and Group Health found depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures but that effective antidepressant medication reverses this outcome. The study looked at 3,359 HIV-infected patients to measure the effects of depression -- with and without SSRIs.
   Similar news · Read more »
   
9. New hope for Huntington's sufferers
   08-22-2007 · EurekAlert!
   A major breakthrough in the understanding and potential treatment of Huntington's disease has been made by scientists at the University of Leeds. Researchers in the university's Faculty of Biological Sciences have discovered that one of the body's naturally occurring proteins is preventing 57 genes from operating normally in the brains of Huntington's sufferers. In addition, the destructive nature of this protein could potentially be halted using drugs that are already being used to help cancer patients.
   Similar news · Read more »
   
10. Seven-point system gauges seriousness of heart failure in elderly
    11-09-2006 · EurekAlert!
    A simple points system may soon help guide treatment of elderly heart failure patients. Researchers at Washington University School of Medicine in St. Louis found that by counting how many of seven easy-to-obtain health factors a patient has, physicians can estimate the patient's risk of dying.
    Similar news · Read more »